Citations (106)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Rohini Kharwade, Nilesh Mahajan, Sachin More, Amol Warokar, Sachin Mendhi, Akshay Dhobley & Devendra Palve. (2023) Effect of PEGylation on drug uptake, biodistribution, and tissue toxicity of efavirenz–ritonavir loaded PAMAM G4 dendrimers. Pharmaceutical Development and Technology 28:2, pages 200-218.
Read now
Read now
Chang Hoon Lee, Francesco Franchi & Dominick J. Angiolillo. (2020) Clopidogrel drug interactions: a review of the evidence and clinical implications. Expert Opinion on Drug Metabolism & Toxicology 16:11, pages 1079-1096.
Read now
Read now
Liting Yan, Fengting Yu, Huimin Zhang, Hongxin Zhao, Linghang Wang, Zaiyan Liang, Xia Zhang, Liang Wu, Hongyuan Liang, Siyuan Yang, Yunxia Tang & Fujie Zhang. (2020) Transmitted and Acquired HIV-1 Drug Resistance from a Family: A Case Study. Infection and Drug Resistance 13, pages 3763-3770.
Read now
Read now
Yali Wang, Erik De Clercq & Guangdi Li. (2019) Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment. Expert Opinion on Drug Metabolism & Toxicology 15:10, pages 813-829.
Read now
Read now
Tomohiko Ichikawa, Hirofumi Tsujino, Takahiro Miki, Masaya Kobayashi, Chiaki Matsubara, Sara Miyata, Taku Yamashita, Kohei Takeshita, Yasushige Yonezawa & Tadayuki Uno. (2018) Allosteric activation of cytochrome P450 3A4 by efavirenz facilitates midazolam binding. Xenobiotica 48:12, pages 1227-1236.
Read now
Read now
Evelyn Rodríguez-Estrada, Mónica Fernández-Sánchez, Jairo Muñoz-Delgado, Ana Fresan-Orellana & Gustavo Reyes-Terán. (2016) Sleep and rest activity measured by wrist actigraphy in an HIV-infected patient with Steven–Johnson syndrome. Biological Rhythm Research 47:1, pages 1-6.
Read now
Read now
Pandurangan Ganapathi & Kilivelu Ganesan. (2015) Synthesis and Characterization of 1,2-Dimethyl Imidazolium Ionic Liquids and Their Catalytic Activities. Synthetic Communications 45:18, pages 2135-2141.
Read now
Read now
Beatriz Larru, Jessica Eby & Elizabeth D Lowenthal. (2014) Antiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz. Pediatric Health, Medicine and Therapeutics 5, pages 29-42.
Read now
Read now
Peter Derek Christian Leutscher, Chalotte Stecher, Merete Storgaard & Carsten Schade Larsen. (2013) Discontinuation of efavirenz therapy in HIV patients due to neuropsychiatric adverse effects. Scandinavian Journal of Infectious Diseases 45:8, pages 645-651.
Read now
Read now
Brookie M Best & Miguel Goicoechea. (2008) Efavirenz – Still First-line King?. Expert Opinion on Drug Metabolism & Toxicology 4:7, pages 965-972.
Read now
Read now
Articles from other publishers (96)
Andrea Angeli. 2024. Metalloenzymes. Metalloenzymes
23
34
.
Sara Bettonte, Mattia Berton, Felix Stader, Manuel Battegay & Catia Marzolini. (2023) Intramuscular cabotegravir and rilpivirine concentrations after switching from efavirenz‐containing regimen. British Journal of Clinical Pharmacology 89:12, pages 3618-3628.
Crossref
Crossref
Ankit Kumar Singh, Adarsh Kumar, Sahil Arora, Raj Kumar, Amita Verma, Habibullah Khalilullah, Mariusz Jaremko, Abdul‐Hamid Emwas & Pradeep Kumar. (2023) Current insights and molecular docking studies of HIV‐1 reverse transcriptase inhibitors. Chemical Biology & Drug Design.
Crossref
Crossref
Ben-Hong Chen, Shuai-Jiang Liu, Qian Zhao, Qiumeng Hou, Jia-Li Yuan, Gu Zhan, Qian-Qian Yang & Wei Huang. (2023) Palladium-catalyzed asymmetric [4+2] annulation of vinyl benzoxazinanones with pyrazolone 4,5-diones to access spirobenzoxazine frameworks. Chemical Communications 59:9, pages 1233-1236.
Crossref
Crossref
Ganesan Kilivelu. 2023. Industrial Applications of Ionic Liquids. Industrial Applications of Ionic Liquids.
Ainur Mukhatayeva, Aidana Mustafa, Natalya Dzissyuk, Alpamys Issanov, Zhussipbek Mukhatayev, Bauyrzhan Bayserkin, Sten H. Vermund & Syed Ali. (2022) Antiretroviral therapy resistance mutations among HIV infected people in Kazakhstan. Scientific Reports 12:1.
Crossref
Crossref
Jinfu Peng, Mayur K. Ladumor & Jashvant D. Unadkat. (2022) Estimation of Fetal-to-Maternal Unbound Steady-State Plasma Concentration Ratio of P-Glycoprotein and/or Breast Cancer Resistance Protein Substrate Drugs Using a Maternal-Fetal Physiologically Based Pharmacokinetic Model. Drug Metabolism and Disposition 50:5, pages 613-623.
Crossref
Crossref
Jose R. Castillo‐Mancilla, Nicholas Musinguzi, Stephen Asiimwe, Mark J. Siedner, Catherine Orrell, David R. Bangsberg & Jessica E. Haberer. (2021) High residual inflammation despite HIV viral suppression: Lessons learned from real‐time adherence monitoring among people with HIV in Africa. HIV Medicine 23:5, pages 465-473.
Crossref
Crossref
Ke‐Zuan Deng, Wen‐Liang Jia & M. Ángeles Fernández‐Ibáñez. (2022) Selective Para‐C−H Alkynylation of Aniline Derivatives by Pd/S,O‐Ligand Catalysis. Chemistry – A European Journal 28:9.
Crossref
Crossref
Sebastian Endres, Emil Karaev, Simon Hanio, Jonas Schlauersbach, Christian Kraft, Tim Rasmussen, Robert Luxenhofer, Bettina Böttcher, Lorenz Meinel & Ann-Christin Pöppler. (2022) Concentration and composition dependent aggregation of Pluronic- and Poly-(2-oxazolin)-Efavirenz formulations in biorelevant media. Journal of Colloid and Interface Science 606, pages 1179-1192.
Crossref
Crossref
I. García-Silva, G. Palestino & O. Gonzalez-Ortega. 2022. Biomedical Innovations to Combat COVID-19. Biomedical Innovations to Combat COVID-19
307
337
.
Pankaj Teli, Nusrat Sahiba, Ayushi Sethiya, Jay Soni & Shikha Agarwal. 2022. Imidazole-Based Drug Discovery. Imidazole-Based Drug Discovery
167
193
.
Yan Cao, Roya Ahmadi, Mohammad Reza Poor Heravi, Alibek Issakhov, Abdol Ghaffar Ebadi & Esmail Vessally. (2021) Recent trends in dehydroxylative trifluoro-methylation, -methoxylation, -methylthiolation, and -methylselenylation of alcohols. RSC Advances 11:62, pages 39593-39606.
Crossref
Crossref
Ramreddy Godela, Vijayalaxmi Kammari, Sowjanya Gummadi & Durgaprasad Beda. (2021) Concurrent estimation of lamivudine, tenofovir disoproxil fumarate, and efavirenz in blended mixture and triple combination tablet formulation by a new stability indicating RP-HPLC method. Future Journal of Pharmaceutical Sciences 7:1.
Crossref
Crossref
Xian-min Meng, Zi-ran Li, Xin-yin Zheng, Yi-xi Liu, Wan-jie Niu, Xiao-yan Qiu & Hong-zhou Lu. (2021) Effect of albumin and CYP2B6 polymorphisms on exposure of efavirenz: A population pharmacokinetic analysis in Chinese HIV-infected adults. European Journal of Pharmaceutical Sciences 167, pages 105986.
Crossref
Crossref
Yijie Hu, Liufeiyang Ye, Jie Chen, Hui Zhang, Hongmei Deng, Jin‐Hong Lin & Weiguo Cao. (2021)
An Efficient Construction of CF
3
‐Substituted Spirooxindole‐Fused Benzo[a]quinolizidines by a Three‐Component Cyclization
. European Journal of Organic Chemistry 2021:30, pages 4405-4408.
Crossref
Crossref
Shilpa Ray, Aswathy Narayanan, Christian G. Giske, Ujjwal Neogi, Anders Sönnerborg & Piotr Nowak. (2020) Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine. ACS Infectious Diseases 7:5, pages 1104-1115.
Crossref
Crossref
Sjoerd Slagman & Wolf-Dieter Fessner. (2021) Biocatalytic routes to anti-viral agents and their synthetic intermediates. Chemical Society Reviews 50:3, pages 1968-2009.
Crossref
Crossref
Jianlin Han, Attila Márió Remete, Luca S. Dobson, Lorand Kiss, Kunisuke Izawa, Hiroki Moriwaki, Vadim A. Soloshonok & David O’Hagan. (2020) Next generation organofluorine containing blockbuster drugs. Journal of Fluorine Chemistry 239, pages 109639.
Crossref
Crossref
Khawla Boudebbous, Houssem Boulebd, Raouf Boulcina, Lamia Bendjeddou, Chawki Bensouici, Hocine Merazig & Abdelmadjid Debache. (2020) Synthesis, crystal structure, biological evaluation, docking study, and DFT calculations of 1-amidoalkyl-2-naphthol derivative. Journal of Molecular Structure 1212, pages 128179.
Crossref
Crossref
Johnson Kai Chun LawLaurie T. ButlerMatthew M. Hamill. (2020) Predictors of Discontinuation of Efavirenz as Treatment for HIV, Due to Neuropsychiatric Side Effects, in a Multi-Ethnic Sample in the United Kingdom. AIDS Research and Human Retroviruses 36:6, pages 459-466.
Crossref
Crossref
Bhola Jaydip, Mori Dhaval, M.M. Soniwala & Jayant Chavda. (2020) Formulation and optimization of liquisolid compact for enhancing dissolution properties of efavirenz by using DoE approach. Saudi Pharmaceutical Journal 28:6, pages 737-745.
Crossref
Crossref
Rajesh K. Singh, Ashima Dhiman, Shallu Chaudhary, Deo Nandan Prasad & Sahil Kumar. (2020) Current Progress in the Multicomponent Catalytic Synthesis of Amidoalkyl- Naphthols: An Update. Current Organic Chemistry 24:5, pages 487-515.
Crossref
Crossref
Dongseong Park, Carina I. Jette, Jiyun Kim, Woo‐Ok Jung, Yongmin Lee, Jongwoo Park, Seungyoon Kang, Min Su Han, Brian M. Stoltz & Sukwon Hong. (2019) Enantioselective Alkynylation of Trifluoromethyl Ketones Catalyzed by Cation‐Binding Salen Nickel Complexes. Angewandte Chemie International Edition 59:2, pages 775-779.
Crossref
Crossref
Dongseong Park, Carina I. Jette, Jiyun Kim, Woo‐Ok Jung, Yongmin Lee, Jongwoo Park, Seungyoon Kang, Min Su Han, Brian M. Stoltz & Sukwon Hong. (2019) Enantioselective Alkynylation of Trifluoromethyl Ketones Catalyzed by Cation‐Binding Salen Nickel Complexes. Angewandte Chemie 132:2, pages 785-789.
Crossref
Crossref
CH. RAMESH, DHARMASOTH RAMA DEVI DEVI, M.N.B. SRINIVAS, S. RADHA KRISHNA, NAGARAJU RAJANA & K. BASAVAIAH. (2020) Development and Validation of RP-Chiral HPLC Method for
Determination of (R)-Enantiomer Excess Content in Efavirenz. Asian Journal of Chemistry 32:9, pages 2208-2212.
Crossref
Crossref
Xue Zhao, Shihai Yang, Saeideh Ebrahimiasl, Sattar Arshadi & Akram Hosseinian. (2019) Synthesis of six-membered cyclic carbamates employing CO2 as building block: A review. Journal of CO2 Utilization 33, pages 37-45.
Crossref
Crossref
Michael M. Lübtow, Malik Salman Haider, Marius Kirsch, Stefanie Klisch & Robert Luxenhofer. (2019) Like Dissolves Like? A Comprehensive Evaluation of Partial Solubility Parameters to Predict Polymer–Drug Compatibility in Ultrahigh Drug-Loaded Polymer Micelles. Biomacromolecules 20:8, pages 3041-3056.
Crossref
Crossref
Pedzisai A. Makoni, Kasongo Wa Kasongo & Roderick B. Walker. (2019) Short Term Stability Testing of Efavirenz-Loaded Solid Lipid Nanoparticle (SLN) and Nanostructured Lipid Carrier (NLC) Dispersions. Pharmaceutics 11:8, pages 397.
Crossref
Crossref
Jie Gao, Yangdan Pan, Yahong Li & Yafei Li. (2019) 1-(2-Amino-5-chlorophenyl)-2,2,2-trifluoroethan-1-one. IUCrData 4:7.
Crossref
Crossref
Aazam Monfared, Saeideh Ebrahimiasl, Mirzaagha Babazadeh, Sattar Arshadi & Esmail Vessally. (2019) Recent advances in decarboxylative trifluoromethyl(thiol)ation of carboxylic acids. Journal of Fluorine Chemistry 220, pages 24-34.
Crossref
Crossref
Kazuki Hirano, Satoshi Gondo, Nagender Punna, Etsuko Tokunaga & Norio Shibata. (2019)
Gas/Liquid‐Phase Micro‐Flow Trifluoromethylation using Fluoroform: Trifluoromethylation of Aldehydes, Ketones, Chalcones, and
N
‐Sulfinylimines
. ChemistryOpen 8:4, pages 406-410.
Crossref
Crossref
Nagender Punna, Kyosuke Harada, Jun Zhou & Norio Shibata. (2019) Pd-Catalyzed Decarboxylative Cyclization of Trifluoromethyl Vinyl Benzoxazinanones with Sulfur Ylides: Access to Trifluoromethyl Dihydroquinolines. Organic Letters 21:5, pages 1515-1520.
Crossref
Crossref
Yao-Bin Shen, Shuai-Shuai Li, Yun-Ming Sun, Liping Yu, Zhi-Hui Hao, Qing Liu & Jian Xiao. (2019)
Organocatalytic C(sp
3
)–H Functionalization of 5-Methyl-2,3-dihydrofuran Derivatives with Trifluoropyruvates via a Sequential
exo
-Tautomerization/Carbonyl-Ene Process
. The Journal of Organic Chemistry 84:5, pages 2779-2785.
Crossref
Crossref
Rakhi Gawali, Jay Trivedi, Sujit Bhansali, Raghunath Bhosale, Dhiman Sarkar & Debashis Mitra. (2018) Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors. European Journal of Medicinal Chemistry 157, pages 310-319.
Crossref
Crossref
Angela M Bengtson, Brian W Pence, Ellen F Eaton, Jessie K Edwards, Joseph J Eron, William C Mathews, Katie Mollan, Richard D Moore, Connall O'Cleirigh, Elvin Geng & Michael J Mugavero. (2017) Patterns of Efavirenz use as First-Line Antiretroviral Therapy in the United States: 1999–2015. Antiviral Therapy 23:4, pages 363-372.
Crossref
Crossref
Jenna Johnston, Catherine Orrell, Peter Smith, Anton Joubert & Lubbe Wiesner. (2018) A validated liquid chromatography/tandem mass spectrometry method for the analysis of efavirenz in 0.2 mg hair samples from human immunodeficiency virus infected patients. Rapid Communications in Mass Spectrometry 32:8, pages 657-664.
Crossref
Crossref
Hina P. A. Khan & Tushar Kanti Chakraborty. (2018)
Diversity-Oriented Approach to
N-
Heterocyclic Compounds from α-Phenyl-β-enamino Ester via a Mitsunobu-Michael Reaction Sequence
. The Journal of Organic Chemistry 83:4, pages 2027-2039.
Crossref
Crossref
Amer M. Alanazi, Ali S. Abdelhameed, Ahmed H. Bakheit, Fahad M. Almutairi, Ayman Alkhider, Rasheed N. Herqash & Ibrahim A. Darwish. (2018) Unraveling the binding characteristics of the anti-HIV agents abacavir, efavirenz and emtricitabine to bovine serum albumin using spectroscopic and molecular simulation approaches. Journal of Molecular Liquids 251, pages 345-357.
Crossref
Crossref
Michel Daudon, Vincent Frochot, Dominique Bazin & Paul Jungers. (2017) Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment. Drugs 78:2, pages 163-201.
Crossref
Crossref
Yu Zheng, Lilu Zhang & Eric Meggers. (2018) Catalytic Enantioselective Synthesis of Key Propargylic Alcohol Intermediates of the Anti-HIV Drug Efavirenz. Organic Process Research & Development 22:1, pages 103-107.
Crossref
Crossref
Mohaned Shilaih, Daniel C Angst, Alex Marzel, Sebastian Bonhoeffer, Huldrych F Günthard & Roger D Kouyos. (2018) Antibacterial Effects of Antiretrovirals, Potential Implications for Microbiome Studies in HIV. Antiviral Therapy 23:1, pages 91-94.
Crossref
Crossref
Pulakesh Das, Satoshi Gondo, Punna Nagender, Hiroto Uno, Etsuko Tokunaga & Norio Shibata. (2018)
Access to benzo-fused nine-membered heterocyclic alkenes with a trifluoromethyl carbinol moiety
via
a double decarboxylative formal ring-expansion process under palladium catalysis
. Chemical Science 9:13, pages 3276-3281.
Crossref
Crossref
K. Shiva Kumar, N. Praveen Kumar, Bandari Rajesham, Gugulothu Kishan, Sravani Akula & Rama Krishna Kancha. (2018)
Silver-catalyzed synthesis of pyrrolopiperazine fused with oxazine/imidazole
via
a domino approach: evaluation of anti-cancer activity
. New Journal of Chemistry 42:1, pages 34-38.
Crossref
Crossref
Sung-Hsi Huang, Shu-Wen Lin, Sui-Yuan Chang, Ya-Ting Lin, Chieh Chiang, Chin-Fu Hsiao, Hsin-Yun Sun, Wen-Chun Liu, Yi-Ching Su, Chien-Ching Hung & Shan-Chwen Chang. (2017) Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy. Scientific Reports 7:1.
Crossref
Crossref
Lilu Zhang & Eric Meggers. (2017) Stereogenic-Only-at-Metal Asymmetric Catalysts. Chemistry - An Asian Journal 12:18, pages 2335-2342.
Crossref
Crossref
Nádia M. Grilo, M. João Correia, Joana P. Miranda, Madalena Cipriano, Jacinta Serpa, M. Matilde Marques, Emília C. Monteiro, Alexandra M.M. Antunes, Lucília N. Diogo & Sofia A. Pereira. (2017) Unmasking efavirenz neurotoxicity: Time matters to the underlying mechanisms. European Journal of Pharmaceutical Sciences 105, pages 47-54.
Crossref
Crossref
Gerd Mikus, Tilman Heinrich, Julia Bödigheimer, Claudia Röder, Anne-Kathrin Matthee, Johanna Weiss, Jürgen Burhenne & Walter E. Haefeli. (2017) Semisimultaneous Midazolam Administration to Evaluate the Time Course of CYP3A Activation by a Single Oral Dose of Efavirenz. The Journal of Clinical Pharmacology 57:7, pages 899-905.
Crossref
Crossref
Motahareh Ahmadi, Hossein Khalili, Ladan Abbasian & Padideh Ghaeli. (2017) Effect of Valerian in Preventing Neuropsychiatric Adverse Effects of Efavirenz in HIV-Positive Patients: A Pilot Randomized, Placebo-Controlled Clinical Trial. Annals of Pharmacotherapy 51:6, pages 457-464.
Crossref
Crossref
Catia Marzolini, Rajith Rajoli, Manuel Battegay, Luigia Elzi, David Back & Marco Siccardi. (2016) Physiologically Based Pharmacokinetic Modeling to Predict Drug–Drug Interactions with Efavirenz Involving Simultaneous Inducing and Inhibitory Effects on Cytochromes. Clinical Pharmacokinetics 56:4, pages 409-420.
Crossref
Crossref
Yu Zheng, Yuqi Tan, Klaus Harms, Michael Marsch, Radostan Riedel, Lilu Zhang & Eric Meggers. (2017) Octahedral Ruthenium Complex with Exclusive Metal-Centered Chirality for Highly Effective Asymmetric Catalysis. Journal of the American Chemical Society 139:12, pages 4322-4325.
Crossref
Crossref
Omran A. Omran, Samia M. Sayed & Mohamed A. Raslan. (2017)
Iminophosphoranes in Heterocyclic Synthesis: A Facile Synthesis of Pyrido[4,3-
D
]Pyrimidine and Pyrido[4,3-
D
][1,3]Oxazine Derivatives via Intermolecular aza-Wittig Reactions
. Journal of Heterocyclic Chemistry 54:2, pages 1103-1108.
Crossref
Crossref
Khairy A. M. El-Bayouki, Wahid M. Basyouni, Tamer K. Khatab, Ezzat M. Kandel, Doria S. Badawy, Ebrahim Abdel-Galil & Ahmed A. El-Henawy. (2017)
Efficient One-pot Synthesis, Antimicrobial and Docking Studies of Some Newer Tetrahydro-4
H
-benzo [1,3-
e
]oxazines and Related β-Acylamino Ketone Derivatives
. Journal of Heterocyclic Chemistry 54:2, pages 1054-1064.
Crossref
Crossref
Raphael de Oliveira Rodrigues, Silvia Helena Barem Rabenhorst, Paulo Germano de Carvalho, Greyce Luri Sasahara, Luciana Mabel Ferreira Vasconcelos, Érico Antônio Gomes de Arruda, Silvia Fernandes Ribeiro da Silva, Ilana Farias Ribeiro & Aparecida Tiemi Nagao-Dias. (2017) Association of <i>IL10, IL4, IFNG</i>, and <i>CTLA4</i> Gene Polymorphisms with Efavirenz Hypersensitivity Reaction in Patients Infected with Human Immunodeficiency Virus. Japanese Journal of Infectious Diseases 70:4, pages 430-436.
Crossref
Crossref
Paul Curley, Rajith K. R. Rajoli, Darren M. Moss, Neill J. Liptrott, Scott Letendre, Andrew Owen & Marco Siccardi. (2017)
Efavirenz Is Predicted To Accumulate in Brain Tissue: an
In Silico
,
In Vitro
, and
In Vivo
Investigation
. Antimicrobial Agents and Chemotherapy 61:1.
Crossref
Crossref
Teresa T. Vo & Sheeba Varghese Gupta. (2016) Role of Cytochrome P450 2B6 Pharmacogenomics in Determining Efavirenz-Mediated Central Nervous System Toxicity, Treatment Outcomes, and Dosage Adjustments in Patients with Human Immunodeficiency Virus Infection. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36:12, pages 1245-1254.
Crossref
Crossref
Rajesh Krishna, Lilly East, Patrick Larson, Tara Siringhaus, Lisa Herpok, Crystal Bethel-Brown, Helen Manthos, John Brejda & Michael Gartner. (2016) Efavirenz does not meaningfully affect the single dose pharmacokinetics of 1200 mg raltegravir. Biopharmaceutics & Drug Disposition 37:9, pages 542-549.
Crossref
Crossref
Collen MasimirembwaCollet DandaraPeter Derek Christian Leutscher. (2016) Rolling out Efavirenz for HIV Precision Medicine in Africa: Are We Ready for Pharmacovigilance and Tackling Neuropsychiatric Adverse Effects?. OMICS: A Journal of Integrative Biology 20:10, pages 575-580.
Crossref
Crossref
Marco Siccardi, Phillip Martin, Darren Smith, Paul Curley, Tom McDonald, Marco Giardiello, Neill Liptrott, Steve Rannard & Andrew Owen. (2016) Towards a rational design of solid drug nanoparticles with optimised pharmacological properties. Journal of Interdisciplinary Nanomedicine 1:3, pages 110-123.
Crossref
Crossref
Cristina Gervasoni, Sara Baldelli, Matteo Cerea, Giovanni Cenderello, Teresa Bini, Stefania Vimercati, Rosaria Iardino, Andrea Gazzaniga, Antonella D'Arminio Monforte, Emilio Clementi & Dario Cattaneo. (2016) Comparison of the In Vivo Pharmacokinetics and In Vitro Dissolution of Branded Versus Generic Efavirenz Formulation in HIV-Infected Patients. Therapeutic Drug Monitoring 38:3, pages 420-422.
Crossref
Crossref
Mônica M. Bastos, Carolina C.P. Costa, Talitha C. Bezerra, Fernando de C. da Silva & Núbia Boechat. (2016) Efavirenz a nonnucleoside reverse transcriptase inhibitor of first-generation: Approaches based on its medicinal chemistry. European Journal of Medicinal Chemistry 108, pages 455-465.
Crossref
Crossref
Rajesh K. Singh, Balpreet Singh, Robita Duvedi & Sahil Kumar. (2014) Sulfanilic acid: a versatile and efficient catalyst among various organoacids screened for the synthesis of 1-amidoalkyl-2-naphthols under solvent-free condition. Research on Chemical Intermediates 41:7, pages 4083-4099.
Crossref
Crossref
Joanna Kryst, Paweł Kawalec & Andrzej Pilc. (2015) Efavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLOS ONE 10:5, pages e0124279.
Crossref
Crossref
Meizhen Feng, Deping Wang, Jay A. Grobler, Daria J. Hazuda, Michael D. Miller & Ming-Tain Lai. (2015)
In Vitro
Resistance Selection with Doravirine (MK-1439), a Novel Nonnucleoside Reverse Transcriptase Inhibitor with Distinct Mutation Development Pathways
. Antimicrobial Agents and Chemotherapy 59:1, pages 590-598.
Crossref
Crossref
Alessandro Schipani, David Back, Andrew Owen, Gerry Davies, Saye Khoo & Marco Siccardi. (2014) Use of In Vitro to In Vivo Extrapolation to Predict the Optimal Strategy for Patients Switching from Efavirenz to Maraviroc or Nevirapine. Clinical Pharmacokinetics 54:1, pages 107-116.
Crossref
Crossref
A.J. Fasunla, B.O. Ogunbosi, G.N. Odaibo, B. Taiwo, O.G.B. Nwaorgu, D.O. Olaleye, R.L. Murphy, I.F. Adewole, P. Kanki & O.O. Akinyinka. (2014) Cleft palate in HIV-exposed newborns of mothers on highly active antiretroviral therapy. Oral Surgery 7, pages 102-106.
Crossref
Crossref
Ujwal Pratim Saikia, Diganta Baruah, Pallab Pahari, Manash Jyoti Borah, Amrit Goswami & Dilip Konwar. (2014) A facile microwave assisted synthesis of spiro-1,3-oxazines from N-(2-(cyclohex-1-en-1-yl)ethyl)amides. Tetrahedron Letters 55:31, pages 4328-4330.
Crossref
Crossref
Gregory Egan, Christine A. Hughes & Margaret L. Ackman. (2014) Drug Interactions Between Antiplatelet or Novel Oral Anticoagulant Medications and Antiretroviral Medications. Annals of Pharmacotherapy 48:6, pages 734-740.
Crossref
Crossref
Panjasaram Naidoo, Vasudevan V. Chetty & Manoranjenni Chetty. (2014) Impact of CYP polymorphisms, ethnicity and sex differences in metabolism on dosing strategies: the case of efavirenz. European Journal of Clinical Pharmacology 70:4, pages 379-389.
Crossref
Crossref
Laurence Borand, Yoann Madec, Didier Laureillard, Monidarin Chou, Olivier Marcy, Phearavin Pheng, Narom Prak, Chindamony Kim, Khemarin Kim Lak, Chanroeun Hak, Bunnet Dim, Eric Nerrienet, Arnaud Fontanet, Thim Sok, Anne E. Goldfeld, François-Xavier Blanc & Anne-Marie Taburet. (2014) Plasma Concentrations, Efficacy and Safety of Efavirenz in HIV-Infected Adults Treated for Tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA Trial). PLoS ONE 9:3, pages e90350.
Crossref
Crossref
Riccardo Wanke, Shrika G. Harjivan, Sofia A. Pereira, M. Matilde Marques & Alexandra M.M. Antunes. (2013) The role of competitive binding to human serum albumin on efavirenz–warfarin interaction: a nuclear magnetic resonance study. International Journal of Antimicrobial Agents 42:5, pages 443-446.
Crossref
Crossref
Marco Siccardi, Catia Marzolini, Kay Seden, Lisa Almond, Anna Kirov, Saye Khoo, Andrew Owen & David Back. (2013) Prediction of drug-drug Interactions Between Various Antidepressants and Efavirenz or Boosted Protease Inhibitors Using a Physiologically Based Pharmacokinetic Modelling Approach. Clinical Pharmacokinetics 52:7, pages 583-592.
Crossref
Crossref
Marco Siccardi, Adeniyi Olagunju, Kay Seden, Farid Ebrahimjee, Steve Rannard, David Back & Andrew Owen. (2013) Use of a physiologically-based pharmacokinetic model to simulate artemether dose adjustment for overcoming the drug-drug interaction with efavirenz. In Silico Pharmacology 1:1.
Crossref
Crossref
Rodrigo Cristofoletti, Anita Nair, Bertil Abrahamsson, D.W. Groot, Sabine Kopp, Peter Langguth, James E. Polli, Vinod P. Shah & Jennifer B. Dressman. (2013) Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Efavirenz. Journal of Pharmaceutical Sciences 102:2, pages 318-329.
Crossref
Crossref
Pek Chong, Paul Sebahar, Michael Youngman, Dulce Garrido, Huichang Zhang, Eugene L. Stewart, Robert T. Nolte, Liping Wang, Robert G. Ferris, Mark Edelstein, Kurt Weaver, Amanda Mathis & Andrew Peat. (2012) Rational Design of Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase. Journal of Medicinal Chemistry 55:23, pages 10601-10609.
Crossref
Crossref
Zhilan Lin, Xueli Zhang, Xinkui You & Yuan Gao. (2012) Facile cleavage of C–C bond: conversion of pyrane derivative to 1,3-oxazin derivative. Tetrahedron 68:33, pages 6759-6764.
Crossref
Crossref
Hans Matter, Marc Nazaré & Stefan Güssregen. 2012. The Importance of Pi‐Interactions in Crystal Engineering. The Importance of Pi‐Interactions in Crystal Engineering
187
232
.
Sofia A. Pereira, Riccardo Wanke, M. Matilde Marques, Emília C. Monteiro & Alexandra M.M. Antunes. 2012. Advances in Molecular Toxicology Volume 6. Advances in Molecular Toxicology Volume 6
1
39
.
Namandjé N. Bumpus. (2011) Efavirenz and 8-hydroxyefavirenz induce cell death via a JNK- and BimEL-dependent mechanism in primary human hepatocytes. Toxicology and Applied Pharmacology 257:2, pages 227-234.
Crossref
Crossref
Christopher A. Kenedi & Harold W. Goforth. (2011) A Systematic Review of the Psychiatric Side-Effects of Efavirenz. AIDS and Behavior 15:8, pages 1803-1818.
Crossref
Crossref
Diana M. Brainard, Larissa A. Wenning, Julie A. Stone, John A. Wagner & Marian Iwamoto. (2011) Clinical Pharmacology Profile of Raltegravir, an HIV-1 Integrase Strand Transfer Inhibitor. The Journal of Clinical Pharmacology 51:10, pages 1376-1402.
Crossref
Crossref
Pauline Byakika-Kibwika, Mohammed Lamorde, Harriet Mayanja-Kizza, Saye Khoo, Concepta Merry & Jean-Pierre Van geertruyden. (2011) Artemether-Lumefantrine Combination Therapy for Treatment of Uncomplicated Malaria: The Potential for Complex Interactions with Antiretroviral Drugs in HIV-Infected Individuals. Malaria Research and Treatment 2011, pages 1-5.
Crossref
Crossref
Ankita Rai & Lal Dhar S. Yadav. (2010) N-Iodosaccharin (NISac): a new reusable catalyst for formal [2+4] cycloaddition of imines and enones. Tetrahedron Letters 51:31, pages 4045-4049.
Crossref
Crossref
Beatriz GrinsztejnGiovanni Di PerriWilliam TownerBrian WoodfallGoedele De SmedtMonika Peeters. (2010) A Review of the Safety and Tolerability Profile of the Next-Generation NNRTI Etravirine. AIDS Research and Human Retroviruses 26:7, pages 725-733.
Crossref
Crossref
Ana Blas-García, Nadezda Apostolova, Daniel Ballesteros, Daniel Monleón, Jose M. Morales, Milagros Rocha, Victor M. Victor & Juan V. Esplugues. (2010) Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells. Hepatology 52:1, pages 115-125.
Crossref
Crossref
Todd T Brown & Grace A McComsey. (2009) Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. Antiviral Therapy 15:3, pages 425-429.
Crossref
Crossref
Joshua J. Kennedy-Smith, Nidhi Arora, J. Roland Billedeau, Jennifer Fretland, Julie Q. Hang, Gabrielle M. Heilek, Seth F. Harris, Donald Hirschfeld, Hassan Javanbakht, Yu Li, Weiling Liang, Ralf Roetz, Mark Smith, Guoping Su, Judy M. Suh, Armando G. Villaseñor, Jeffrey Wu, Dennis Yasuda, Klaus Klumpp & Zachary K. Sweeney. (2010) Synthesis and biological activity of new pyridone diaryl ether non-nucleoside inhibitors of HIV-1 reverse transcriptase. MedChemComm 1:1, pages 79.
Crossref
Crossref
Mark Boyd & David A. Cooper. 2010. Antibiotic and Chemotherapy. Antibiotic and Chemotherapy
427
451
.
Mark J. AtkinsonJeffrey J. Petrozzino. (2009) An Evidence-Based Review of Treatment-Related Determinants of Patients' Nonadherence to HIV Medications. AIDS Patient Care and STDs 23:11, pages 903-914.
Crossref
Crossref
Bernardino Roca. (2009) Farmacogenómica de los antirretrovirales. Medicina Clínica 132:7, pages 268-271.
Crossref
Crossref
Zachary K. Sweeney, Joshua J. Kennedy‐Smith, Jeffrey Wu, Nidhi Arora, J. Roland Billedeau, James P. DavidsonJennifer FretlandJulie Q. HangGabrielle M. HeilekSeth F. HarrisDonald Hirschfeld, Petra InbarHassan JavanbakhtJesper A. JerneliusQingwu JinYu LiWeiling Liang, Ralf Roetz, Keshab SarmaMark Smith, Dimitrio StefanidisGuoping SuJudy M. Suh, Armando G. VillaseñorMichael WelchFang‐Jie ZhangKlaus Klumpp. (2009) Diphenyl Ether Non‐Nucleoside Reverse Transcriptase Inhibitors with Excellent Potency Against Resistant Mutant Viruses and Promising Pharmacokinetic Properties. ChemMedChem 4:1, pages 88-99.
Crossref
Crossref
Marian Iwamoto, Larissa A. Wenning, Amelia S. Petry, Martine Laethem, Marina De Smet, James T. Kost, Sheila A. Breidinger, Eric C. Mangin, Neal Azrolan, Howard E. Greenberg, Wouter Haazen, Julie A. Stone, Keith M. Gottesdiener & John A. Wagner. (2008) Minimal Effects of Ritonavir and Efavirenz on the Pharmacokinetics of Raltegravir. Antimicrobial Agents and Chemotherapy 52:12, pages 4338-4343.
Crossref
Crossref
Serge Schneider, Alexandra Peltier, Alain Gras, Vic Arendt, Christine Karasi-Omes, Anastasie Mujawamariwa, Patrick C Ndimubanzi, Gilles Ndayisaba & Robert Wennig. (2008) Efavirenz in Human Breast Milk, Mothers', and Newborns' Plasma. JAIDS Journal of Acquired Immune Deficiency Syndromes 48:4, pages 450-454.
Crossref
Crossref
Lal Dhar S. Yadav, Vishnu P. Srivastava, Vijai K. Rai & Rajesh Patel. (2008) Diversity oriented synthesis of fused-ring 1,3-oxazines from carbohydrates as biorenewable feedstocks. Tetrahedron 64:19, pages 4246-4253.
Crossref
Crossref
Andrew P RiceRichard E Sutton. (2007) Targeting protein–protein interactions for HIV therapeutics. Future HIV Therapy 1:4, pages 369-385.
Crossref
Crossref
Courtney V Fletcher. (2007) Translating Efficacy into Effectiveness in Antiretroviral Therapy. Drugs 67:14, pages 1969-1979.
Crossref
Crossref